Inozyme Pharma Inc.

11/15/2021 | Press release | Distributed by Public on 11/15/2021 06:37

Inozyme Pharma Announces Dosing of First Patient in First-in-Human Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency